Zobrazeno 1 - 10
of 171
pro vyhledávání: '"Kuniaki Itoh"'
Autor:
Mitsutoshi Kurosawa, Kenichi Yoshimura, Tomohiro Kinoshita, Harumi Kaba, Motoko Yamaguchi, Tomomitsu Hotta, Michinori Ogura, Shigeo Nakamura, Yoshitaka Imaizumi, Masanori Shimoyama, Koichi Ohshima, Kensei Tobinai, Takashi Watanabe, Kuniaki Itoh, Hirokazu Nagai, Kunihiro Tsukasaki, Kiyoshi Mukai, Shuichi Ota
Publikováno v:
Journal of Clinical and Experimental Hematopathology : JCEH
The clinical characteristics of B-cell lymphoma (BCL) were studied through the combined analysis of six clinical trials conducted by the Japan Clinical Oncology Group - Lymphoma Study Group (JCOG-LSG) for aggressive lymphoma in the 1990s, before the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59a7c8e2c1ec42da04976173c64c7806
https://doi.org/10.3960/jslrt.20062
https://doi.org/10.3960/jslrt.20062
Autor:
Shinichi Masuda, Yoshikazu Utsu, Hiroyuki Irisawa, Nobuyuki Aotsuka, Hideki Tsujimura, Tadahiko Igarashi, Kunihiro Tsukasaki, Kuniaki Itoh, Hisashi Wakita
Publikováno v:
Leukemia & Lymphoma. 59:1606-1613
The aim of this randomized phase II study was to improve the treatment delays and discontinuations associated with bendamustine use by comparing the effect of Benda-14 (intravenous bendamustine, 120 mg/m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7732a9747dbc221f1f1a21c80b9c71be
https://doi.org/10.1080/10428194.2017.1390233
https://doi.org/10.1080/10428194.2017.1390233
Autor:
Yasushi Onishi, Shinichiro Yoshida, Michinori Ogura, Hideki Tsujimura, Yukiyoshi Moriuchi, Masashi Sawa, Isamu Sugiura, Kuniaki Itoh, Akihiro Tomita, Tomohiro Kinoshita, Sachiko Suzuki, Rika Sakai, Takuya Fukushima, Eiji Tanaka, Ilseung Choi, Ritsuro Suzuki, Dai Maruyama, Kisato Nosaka, Tsutomu Takahashi, Masanobu Nakata, Shigeru Kusumoto, Masashi Mizokami, Ryuzo Ueda, Toshiki Uchida, Hiroyuki Takahashi, Yasuhito Tanaka, Noriyasu Fukushima, Minoru Kojima, Takayo Suzuki, Mika Kohri, Takashi Watanabe, Rumiko Okamoto, Yoshiko Atsuta, Masataka Okamoto
Publikováno v:
Journal of hepatology. 73(2)
Background & Aims HBV reactivation is a risk in patients receiving anti-CD20 antibodies for the treatment of lymphoma. The purpose of this post hoc analysis was to evaluate the efficacy of an ultra-high sensitivity HBsAg assay to guide preemptive ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcbee9f442e4baf3dea3eedb910e8e4d
https://pubmed.ncbi.nlm.nih.gov/32194183
https://pubmed.ncbi.nlm.nih.gov/32194183
Complications and outcomes in diffuse large B-cell lymphoma with gastric lesions treated with R-CHOP
Autor:
Kuniaki Itoh, Kazuhiro Kaneko, Tomonori Yano, Hiroe Fuse, Sachiko Seo, Kunihiro Tsukasaki, Genichiro Ishii, Tomohiro Kadota
Publikováno v:
Cancer Medicine
Standard therapy for gastric diffuse large B‐cell lymphoma (DLBCL) is considered to be chemotherapy with or without involved‐field radiation therapy. Although R‐CHOP therapy alone is widely used for DLBCL with gastric lesions (DLBCL‐GL), the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::950fe5addadb92c74bf70f470f64a37f
https://pubmed.ncbi.nlm.nih.gov/30730104
https://pubmed.ncbi.nlm.nih.gov/30730104
Autor:
Tsutomu Takahashi, Mika Kohri, Eiji Tanaka, Hiroyuki Takahashi, Masashi Sawa, Ritsuro Suzuki, Kuniaki Itoh, Sachiko Suzuki, Ryuzo Ueda, Akihiro Tomita, Michinori Ogura, Yasushi Onishi, Takayo Suzuki, Dai Maruyama, Shinichiro Yoshida, Takashi Watanabe, Yukiyoshi Moriuchi, Kisato Nosaka, Takuya Fukushima, Ilseung Choi, Masanobu Nakata, Rika Sakai, Masashi Mizokami, Masataka Okamoto, Rumiko Okamoto, Yoshiko Atsuta, Minoru Kojima, Hirotaka Takasaki, Shigeru Kusumoto, Yasuhito Tanaka, Noriyasu Fukushima, Tomohiro Kinoshita, Hideki Tsujimura, Isamu Sugiura, Toshiki Uchida
Publikováno v:
Clinical Infectious Diseases. 61:719-729
BACKGROUND There is no standard management of reactivation of hepatitis B virus (HBV) infection in HBV-resolved patients without hepatitis B surface antigen (HBsAg), but with antibodies against hepatitis B core antigen and/or antibodies against HBsAg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddb8a3de1a006f40024d35159784fef8
https://doi.org/10.1093/cid/civ344
https://doi.org/10.1093/cid/civ344
Autor:
Tomohiro Kinoshita, Takashi Watanabe, Kuniaki Itoh, Kenichi Yoshimura, Kensei Tobinai, Michinori Ogura, Motoko Yamaguchi, Mitsutoshi Kurosawa, Yoshitaka Imaizumi, Shuichi Ota, Harumi Kaba, Kiyoshi Mukai, Shigeo Nakamura, Koichi Ohshima, Tomomitsu Hotta, Kunihiro Tsukasaki, Hirokazu Nagai, Masanori Shimoyama
Publikováno v:
Journal of Clinical & Experimental Hematopathology; 2021, Vol. 61 Issue 1, p35-41, 7p
Autor:
Shigeo Nakamura, Masahiko Oguchi, Tomohiro Kinoshita, Nobuko Kubota, Noriko Usui, Naoki Ishizuka, Tadashi Yoshino, Kunihiro Tsukasaki, Kuniaki Itoh, Yukio Kobayashi, Kana Miyazaki, Kenichi Ishizawa, Yasushi Isobe, Yoshihiro Matsuno, Kazuo Oshimi, Kensei Tobinai, Katsuyoshi Takata, Motoko Yamaguchi, Izumi Wasada
Publikováno v:
Cancer Science
Concurrent chemoradiotherapy has become one of the standard management approaches for newly diagnosed localized nasal natural killer (NK)/T-cell lymphoma (NKTCL). Few data are available on the prognostic biomarkers of NKTCL among patients treated wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afc1cd30160a4e005d677075b4b75df2
https://doi.org/10.1111/cas.12526
https://doi.org/10.1111/cas.12526
Autor:
Wing Y. Au, Keiko Yamamoto, Takashi Terauchi, Yoshinobu Tanaka, Yoshihiro Matsuno, Takashi Shimamoto, Hwei-Fang Tien, Masahiko Mori, Michinori Ogura, Kensei Tobinai, Sung Yong Oh, Kuniaki Itoh, Kazuhito Yamamoto, Kiyoshi Ando, Kenichi Ishizawa, Won Seog Kim, Tatsuya Suzuki
Publikováno v:
British Journal of Haematology
Although initial rituximab-containing chemotherapies achieve high response rates, indolent B-cell non-Hodgkin lymphoma (B-NHL), such as follicular lymphoma (FL), is still incurable. Therefore, new effective agents with novel mechanisms are anticipate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eae16ceb07e25064069d9742565115d
http://europepmc.org/articles/PMC4282031
http://europepmc.org/articles/PMC4282031
Publikováno v:
Neurologia medico-chirurgica
A 52-year-old man with a history of malignant lymphoma of the cecum presented with lancinating facial pain in the left. Magnetic resonance imaging (MRI) revealed a tumor in the Meckel's cave extending along the trigeminal nerve. The tumor was partial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aff01975aed80e6f22a5524540301942
https://doi.org/10.2176/nmc.cr2013-0095
https://doi.org/10.2176/nmc.cr2013-0095
Autor:
Mitsutoshi Kurosawa, Naokuni Uike, Yasuo Ohashi, Takashi Terauchi, Kuniaki Itoh, Michinori Ogura, Kazuhito Yamamoto, Hirokazu Nagai, Akihiro Tomita, Shigeru Nawano, Masafumi Taniwaki, Shigeo Mori, Tadahiko Igarashi, Kensei Tobinai, Kiyoshi Ando, Yoshiaki Kuroda
Publikováno v:
International journal of hematology. 104(6)
Recent large-scale randomized clinical trials in Europe and the US demonstrated that maintenance therapy with rituximab significantly improved the progression-free survival (PFS) in indolent B-cell non-Hodgkin lymphoma (B-NHL) patients, especially th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::160448bb3e7682dcabb2312c6e93b1d7
https://pubmed.ncbi.nlm.nih.gov/27896571
https://pubmed.ncbi.nlm.nih.gov/27896571